Search people, articles, bills, and more
This bill matters because it tries to address a potential challenge for vulnerable Medicare patients in long-term care settings. Pharmacies that serve these facilities often have unique and higher costs associated with specialized packaging, delivery, and services tailored to this population. With new federal rules allowing Medicare to negotiate lower drug prices, there's concern that the overall payments to pharmacies for some drugs might decrease.
If long-term care pharmacies face financial difficulties, it could lead to service reductions or even closures, making it harder for residents in nursing homes and similar facilities to get their vital medications. This bill aims to prevent such disruptions by providing temporary financial support to these pharmacies, thereby trying to ensure that access to necessary drugs for Medicare beneficiaries in long-term care remains uninterrupted, particularly in areas where options might already be limited.
No reactions yet. Be the first to weigh in.
This bill matters because it tries to address a potential challenge for vulnerable Medicare patients in long-term care settings. Pharmacies that serve these facilities often have unique and higher costs associated with specialized packaging, delivery, and services tailored to this population. With new federal rules allowing Medicare to negotiate lower drug prices, there's concern that the overall payments to pharmacies for some drugs might decrease.
If long-term care pharmacies face financial difficulties, it could lead to service reductions or even closures, making it harder for residents in nursing homes and similar facilities to get their vital medications. This bill aims to prevent such disruptions by providing temporary financial support to these pharmacies, thereby trying to ensure that access to necessary drugs for Medicare beneficiaries in long-term care remains uninterrupted, particularly in areas where options might already be limited.
An AI model extracted this from the bill’s official record and can make mistakes. Check the official text ↗ (opens in new tab)
An AI model extracted this from the bill’s official record and can make mistakes. Check the official text ↗ (opens in new tab)
| AMOUNT | PROGRAM | TYPE | YEARS |
|---|---|---|---|
| aggregate amount of supply fees paid | Medicare Prescription Drug Program (Part D) | mandatory | 2026 and 2027 |
An AI model extracted this from the bill’s official record and can make mistakes. Check the official text ↗ (opens in new tab)
| TYPE | AMOUNT | WHO |
|---|---|---|
| civil | Not less than $10,000 for each failure | Each PDP sponsor of a prescription drug plan and MA organization offering an MA-PD plan that fails to pay a supply fee |